CoChat

p53 as a hub in cellular redox regulation and therapeutic target in cancer

Open access
Eriksson, Sofi E, Ceder, Sophia, Bykov, Vladimir J N, Wiman, Klas G · 2019 · Journal of Molecular Cell Biology

The DOI matches its Crossref record; 130 of the 132 references it cites were found in a registry or an index.

Abstract

The TP53 tumor suppressor gene encodes a DNA-binding transcription factor that regulates multiple cellular processes including cell growth and cell death. The ability of p53 to bind to DNA and activate transcription is tightly regulated by post-translational modifications and is dependent on a reducing cellular environment. Some p53 transcriptional target genes are involved in regulation of the cellular redox homeostasis, e.g. TIGAR and GLS2. A large fraction of human tumors carry TP53 mutations, most commonly missense mutations that lead to single amino acid substitutions in the core domain. Mutant p53 proteins can acquire so called gain-of-function activities and influence the cellular redox balance in various ways, for instance by binding of the Nrf2 transcription factor, a major regulator of cellular redox state. The DNA-binding core domain of p53 has 10 cysteine residues, three of which participate in holding a zinc atom that is critical for p53 structure and function. Several novel compounds that refold and reactivate missense mutant p53 bind to specific p53 cysteine residues. These compounds can also react with other thiols and target components of the cellular redox system, such as glutathione. Dual targeting of mutant p53 and redox homeostasis may allow more efficient treatment of cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jmcb/mjz005

Cites

130 of 130 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Overview of redox homeostasis. The two main antioxidant systems in the cell are the Trx and GSH systems (green box). p53 regulates several components of the antioxidant systems, marked by . Oxidative phosphorylation in mitochondria is a major source of oxygen species, but such molecules can also be induced by radiation and chemotherapy (red box). Cells can adapt to oxidative stress by activation of the master antioxidant transcription factor Nrf2 that upregulates expression of genes with AREs, such as genes in the GSH and Trx systems. Nrf2 levels are low under unstressed conditions due to proteasomal degradation induced by the KEAP1 protein. Oxidation of KEAP1 cysteines upon oxidative stress inhibits KEAP1 ubiquitin ligase activity, leading to Nrf2 accumulation (blue box) and activation of ARE genes. The Trx system consists of TrxR and Trx and reduces substrates such as Prx and cystine. GSH is used as a cofactor by glutathione GST, Grx, and GPx. GSSG is restored by GR. Both antioxidant systems are dependent on NADPH as a supplier of electrons, since TrxR and GR utilize NADPH as a cofactor. Major NADPH-generating pathways include IDH through α-ketoglutarate production, ME through pyruvate metabolism, and the PPP (gray box). NADPH availability is regulated through the p53 target TIGAR that promotes NADPH production via PPP and through p53-mediated inhibition of G6PD that controls the first and rate-limiting step of PPP.
Figure 1 Overview of redox homeostasis. The two main antioxidant systems in the cell are the Trx and GSH systems (green box). p53 regulates several components of the antioxidant systems, marked by . Oxidative phosphorylation in mitochondria is a major source of oxygen species, but such molecules can also be induced by radiation and chemotherapy (red box). Cells can adapt to oxidative stress by activation of the master antioxidant transcription factor Nrf2 that upregulates expression of genes with AREs, such as genes in the GSH and Trx systems. Nrf2 levels are low under unstressed conditions due to proteasomal degradation induced by the KEAP1 protein. Oxidation of KEAP1 cysteines upon oxidative stress inhibits KEAP1 ubiquitin ligase activity, leading to Nrf2 accumulation (blue box) and activation of ARE genes. The Trx system consists of TrxR and Trx and reduces substrates such as Prx and cystine. GSH is used as a cofactor by glutathione GST, Grx, and GPx. GSSG is restored by GR. Both antioxidant systems are dependent on NADPH as a supplier of electrons, since TrxR and GR utilize NADPH as a cofactor. Major NADPH-generating pathways include IDH through α-ketoglutarate production, ME through pyruvate metabolism, and the PPP (gray box). NADPH availability is regulated through the p53 target TIGAR that promotes NADPH production via PPP and through p53-mediated inhibition of G6PD that controls the first and rate-limiting step of PPP.CC BY-NC · PubMed Central
Figure 2 Regulation of redox homeostasis by wild-type p53. Normal wild-type (wt) p53 function is dependent on a reducing environment, while oxidative conditions can inhibit p53. p53 antioxidant activity induces targets such as GPx1, GLS2, TIGAR, and TP53INP. In addition, p53 induces p21 and SESN2 that stabilize the master antioxidant regulator Nrf2, which leads to transactivation of ARE genes and a reducing milieu via GSH and Trx. p53 also induces pro-oxidant targets such as Puma, Bax, Noxa, PIG3, FDXR, and SCO2, and thereby promotes cell death by apoptosis. Furthermore, p53 can transrepress the SLC7A11 gene and directly inhibit G6PD via protein binding. Nrf2 induces MDM2 that targets p53 for degradation in the proteasome, thus antagonizing p53 activity. Green and red indicate antioxidant and pro-oxidant activities, respectively. Transcriptional regulation is marked by .
Figure 2 Regulation of redox homeostasis by wild-type p53. Normal wild-type (wt) p53 function is dependent on a reducing environment, while oxidative conditions can inhibit p53. p53 antioxidant activity induces targets such as GPx1, GLS2, TIGAR, and TP53INP. In addition, p53 induces p21 and SESN2 that stabilize the master antioxidant regulator Nrf2, which leads to transactivation of ARE genes and a reducing milieu via GSH and Trx. p53 also induces pro-oxidant targets such as Puma, Bax, Noxa, PIG3, FDXR, and SCO2, and thereby promotes cell death by apoptosis. Furthermore, p53 can transrepress the SLC7A11 gene and directly inhibit G6PD via protein binding. Nrf2 induces MDM2 that targets p53 for degradation in the proteasome, thus antagonizing p53 activity. Green and red indicate antioxidant and pro-oxidant activities, respectively. Transcriptional regulation is marked by .CC BY-NC · PubMed Central
Figure 3 Multiple effects of mutant p53 on redox homeostasis. Mutant p53 interacts with Nrf2 and disrupts the ARE transcription program governed by Nrf2, leading to activation of some genes (cytosolic TrxR1 and Trx) and repression of others (HO-1, NQO1, and SLC7A11). The mutant p53–Nrf2 interaction also causes induction of genes such as the PSMA2 and PSMC1 proteasome subunit genes. Mutant p53 promotes shifts in glycolytic metabolism (the Warburg effect) via upregulation of GLUT 1/3/5/6, HKIII, and GPI and stimulates angiogenesis via HIF1 and VEGF, affecting redox homeostasis. Mutant p53 may also exert a dominant-negative effect on co-expressed wild-type p53, thus inhibiting its regulation of the redox balance. Green and red indicate antioxidant and pro-oxidant activities, respectively.
Figure 3 Multiple effects of mutant p53 on redox homeostasis. Mutant p53 interacts with Nrf2 and disrupts the ARE transcription program governed by Nrf2, leading to activation of some genes (cytosolic TrxR1 and Trx) and repression of others (HO-1, NQO1, and SLC7A11). The mutant p53–Nrf2 interaction also causes induction of genes such as the PSMA2 and PSMC1 proteasome subunit genes. Mutant p53 promotes shifts in glycolytic metabolism (the Warburg effect) via upregulation of GLUT 1/3/5/6, HKIII, and GPI and stimulates angiogenesis via HIF1 and VEGF, affecting redox homeostasis. Mutant p53 may also exert a dominant-negative effect on co-expressed wild-type p53, thus inhibiting its regulation of the redox balance. Green and red indicate antioxidant and pro-oxidant activities, respectively.CC BY-NC · PubMed Central
Figure 4 Mutant p53 rescue and induction of oxidative stress and cell death by thiol-binding small molecules. The DNA binding core domain of p53 has 10 cysteine residues with variable degrees of reactivity (illustrated by the yellow–green gradient). Cys182 and Cys277, located on the surface of p53, are highly reactive, whereas Cys176, Cys238, and Cys242 are protected from oxidation by coordinating a zinc atom (marked in brown). Mutations in p53 can cause protein unfolding and exposure of cysteine residues. Several mutant p53-reactivating compounds are electrophiles that bind to cysteines in mutant p53, leading to thermostabilization and induction of p53 target genes, and ultimately tumor cell death. The compound 3-benzoylacrylic acid (3BA) has been shown to bind preferentially to Cys124 and Cys141. Sulfonylpyrimidines (SP) such as PK11007 attack Cys182 and Cys277. Methylene quinuclidinone (MQ), the conversion product of APR-246 and PRIMA-1, targets Cys277 and Cys124. This type of compounds can also react with other nucleophiles in the cell, mainly protein cysteines (R-S–) and selenocysteines (R-Se–), and GSH. MQ has been shown to deplete GSH and inhibit the selenoprotein TrxR1 as well as Trx and Grx, leading to oxidative stress that presumably contributes to tumor cell death. Zinc chelation by the compound ZMC1 reactivates certain forms of mutant p53 and also has redox effects. Stromal cells in the tumor microenvironment, e.g. cancer-associated fibroblasts (CAFs), have been shown to produce nucleophiles that may contribute to cancer cell resistance to alkylating chemotherapeutic agents. Upper panel shows a combined cartoon/mesh of the wild-type p53 core structure from 1tup.pdb crystal structure file (Cho et al., 1994) uploaded from the NCBI library (https://www.ncbi.nlm.nih.gov) and modified by open-source PyMOL molecular graphics software (DeLano Scientific).
Figure 4 Mutant p53 rescue and induction of oxidative stress and cell death by thiol-binding small molecules. The DNA binding core domain of p53 has 10 cysteine residues with variable degrees of reactivity (illustrated by the yellow–green gradient). Cys182 and Cys277, located on the surface of p53, are highly reactive, whereas Cys176, Cys238, and Cys242 are protected from oxidation by coordinating a zinc atom (marked in brown). Mutations in p53 can cause protein unfolding and exposure of cysteine residues. Several mutant p53-reactivating compounds are electrophiles that bind to cysteines in mutant p53, leading to thermostabilization and induction of p53 target genes, and ultimately tumor cell death. The compound 3-benzoylacrylic acid (3BA) has been shown to bind preferentially to Cys124 and Cys141. Sulfonylpyrimidines (SP) such as PK11007 attack Cys182 and Cys277. Methylene quinuclidinone (MQ), the conversion product of APR-246 and PRIMA-1, targets Cys277 and Cys124. This type of compounds can also react with other nucleophiles in the cell, mainly protein cysteines (R-S–) and selenocysteines (R-Se–), and GSH. MQ has been shown to deplete GSH and inhibit the selenoprotein TrxR1 as well as Trx and Grx, leading to oxidative stress that presumably contributes to tumor cell death. Zinc chelation by the compound ZMC1 reactivates certain forms of mutant p53 and also has redox effects. Stromal cells in the tumor microenvironment, e.g. cancer-associated fibroblasts (CAFs), have been shown to produce nucleophiles that may contribute to cancer cell resistance to alkylating chemotherapeutic agents. Upper panel shows a combined cartoon/mesh of the wild-type p53 core structure from 1tup.pdb crystal structure file (Cho et al., 1994) uploaded from the NCBI library (https://www.ncbi.nlm.nih.gov) and modified by open-source PyMOL molecular graphics software (DeLano Scientific).CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Cited by

See all 123

Metadata

Authors
Eriksson, S. E., Ceder, S., Bykov, V. J. N., & Wiman, K. G.
Affiliations
Karolinska Institutet (SE)
Corresponding author
Wiman, Klas G
Venue
Journal of Molecular Cell Biology
Published
2019-02-14
Volume
11
Issue
4
Pages
330-341
ISSN
  • 1674-2788 (ISSN-L)
  • 1759-4685
OpenAlex
W2911745809
Cited by
123
References
132
Citations by year
2026: 12 · 2025: 17 · 2024: 19 · 2023: 18 · 2022: 15 · 2021: 20 · 2020: 13 · 2019: 8
FWCI
1.33
Type
journal article
Language
en
Open access
Locations
  • Journal of Molecular Cell Biology (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • Swedish Medical Research Council
  • Swedish Cancer Fund
  • Swedish Childhood Cancer Fund
  • Radiumhemmets Forskningsfonder
  • Knut & Alice Wallenberg Foundation
  • European Research Council
  • Aprea Therapeutics AB
  • Karolinska Institutet
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
Keywords
TP53, p53, cellular redox homeostasis, TP53 mutation, missense mutations, Nrf2, TIGAR, GLS2, zinc binding, glutathione, cancer therapy, transcriptional regulation
MeSH terms
Antioxidants, DNA, Humans, Neoplasms, Sulfhydryl Compounds, Tumor Suppressor Protein p53, Oxidative Stress, Mutation, Missense, Small Molecule Libraries, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.